Major ocular complications after organ transplantation

Indian Journal of Ophthalmology

Volumn 52, Issue 2, 2004, Pages 95-97

  Lanzetta, Paolo ^a   Monaco, Pietro ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; STEROID; TACROLIMUS;

ABDUCENS NERVE PARALYSIS; ALLOGENIC BONE MARROW TRANSPLANTATION; BRAIN PSEUDOTUMOR; CATARACT; CEREBRAL BLINDNESS; DISEASE EXACERBATION; EDEMA; EDITORIAL; EYE DISEASE; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR PRESSURE ABNORMALITY; ISCHEMIC OPTIC NEUROPATHY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; NEUROTOXICITY; NONHUMAN; ORGAN TRANSPLANTATION; PTOSIS; RAT; RETINA ISCHEMIA; RETINOPATHY; RISK ASSESSMENT; SYSTEMIC DISEASE; VISUAL IMPAIRMENT; WHOLE BODY RADIATION;

EYE DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; TRANSPLANTATION CONDITIONING;

EID: 3142736438     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Shimmyo A, Miyazaky S, Onoe S, et al. Ocular complications after renal transplantation. Nippon Ganka Gakkai Zasshi 1997; 101:220-6
2. Nishimoto K, Sasaki K, Yamamura T, Ishikawa I, Shinoda A. Cataract in renal transplantation recipients with combination ciclosporine treatment. Lens Eye Toxic Res 1992; 9:455-67
3. Tichelli A. Late ocular complications after bone marrow transplantation. Nouv Rev Fr Hematol 1994; 36 Suppl 1:S79-82
4. Gass JDM, Little HL. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid theraphy. Ophthalmology 1995; 102:737-747
5. Fawzi AA, Cunningham ET Jr. Central serous chorioretinopathy after bone marrow transplantation. Am J Ophthalmol 2001; 131:804-5
6. Gass JDM, Slamovits TL, Fuller DG, et al: Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol 1992; 110:1717-22
7. Bandello F, Incorvaia C, Rosa N et al. Bilateral central serous chorioretinopathy in a patient treated with systemic corticosteroids for non-Hodgkin lymphoma. Eur J Ophthalmol 2002; 12:123-26
8. Lopez-Jimenez J, Sanchez A, Fernandez CS et al. Cyclosporine-induced retinal toxic blindness. Bone Marrow Transplant 1997; 20:243-45
9. O'Riordan JM, FitzSimon S, O'Connor M, McCann SR. Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine. Bone Marrow Transplant 1994; 13:101-4
10. Gloor B, Gratwohl A, Hahn H et al. Multiple cotton-wool spots following bone marrow transplantation for treatment of acute lymphatic leukemia. Br J Ophthalmol 1985; 69:320-5
11. Bernauer W, Gratwohl A, Keller A, Daicker B. Microvasculopathy in the ocular fundus after bone marrow transplantation. Ann Intern Med 1991; 115:925-30
12. Zoja C, Furci L, Ghilardi F et al. Cyclosporine-induced endothelial cell injury. Lab Invest 1986; 55:455-462
13. Yamani A, Myers-Powell BA, Whitcup SB et al. Visual loss after renal transplantation. Retina 2001; 21:553-559
14. Coskuncan NM, Jabs DA, Dunn JP et al. The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol 1994; 112:372-79
15. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000; 13:313-26
16. Avery R, Jabs DA, Wingard JR et al. Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity. Ophthalmology 1991; 98:1294-1301
17. Katz B. Disc edema subsequent to renal transplantation. Surv Ophthalmol 1997; 41:315-20
18. Cruz OA, Fogg SG, Roper-Hall G. Pseudotumor cerebri associated with cyclosporine use. Am J Ophthalmol 1996; 122:436-37
19. Reece DE, Frei-Lahr DA, Shepard JD et al. Neurologic complications in allogenic bone marrow transplant patients receiving cyclosporine. Bone Marrow Transplant 1991; 8:393-401
20. Openshaw H, Slatkin NE, Smith E. Eye movement disorders in bone marrow transplant patients on cyclosporine and ganciclovir. Bone Marrow Transplant 1997; 19:503-5
21. Ishida H, Mitamura T, Takahashi Y et al. Cataract development induced by repeated oral dosing with FK 506 (tacrolimus) in adult rats. Toxicology 1997; 123:167-75
22. Brazis PW, Spivey JR, Bolling JP et al. A case of bilateral optic neuropathy in a patient on tacrolimus (FK 506) therapy after liver transplantation. Am J Ophthalmol 2000; 129:536-38
23. Devine SM, Newman NJ, Siegel JL et al Tacrolimus (FK 506)-induced cerebral blindness following bone marrow transplantation. Bone Marrow Transplant 1996; 18:569-72
24. Steg RE, Kessinger A, Wszolek ZK. Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. Bone Marrow Transplant 1999; 23:959-62
25. Shutter LA, Green JP, Newman NJ et al. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology 1993; 43:2417-18.